Osteoporosis is a common complication of ... with liver disease can be contrasted with the traditional views of the bone remodeling process. Figure 1: Factors that affect bone turnover in patients ...

The discovery of a family with sequence similarity 102 member A (Fam102a) protein as a novel bone remodeling factor that regulates both osteoclast and osteoblast differentiation can aid the ...

The authors concluded that long-term bisphosphonate therapy for osteoporosis does not result in increased microdamage of the iliac bone in postmenopausal women, despite reduced bone remodeling.

Osteoporosis results in over nine million fractures per year at a cost of more than US$50 billion. Bone mass and strength are maintained by the bone remodeling cycle involving the integrated ...

An impaired bone remodeling process can result in fragile bones and eventually lead to detrimental health conditions such as osteoporosis and joint fractures. Therefore, research into bone ...

An impaired bone remodeling process can result in fragile bones and eventually lead to detrimental health conditions such as osteoporosis and joint fractures. Therefore, research into bone ...

An impaired bone remodeling process can result in fragile bones and eventually lead to detrimental health conditions such as osteoporosis and joint fractures. Therefore, research into bone ...

Osteoporosis: the ‘silent' condition Roughly ... During sleep, the body undergoes bone remodeling. This is when old tissue is ...

They undergo a continuous remodeling process ... with calcium absorption and increase the risk of osteoporosis. Other factors affecting bone health include body weight (being underweight increases ...

These pathophysiological considerations provide a basis for the development of treatments for osteoporosis. Therapy has been aimed mainly at correction of the imbalance between bone resorption and ...

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has highlighted the role of osteogenic CpG oligodeoxynucleotide (iSN40 ...